{"preliminary_commentary":{"by_channel":{"x_thread":3},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build."},"free_build":{"available":false},"name":"NCT06671379","nct_id":"NCT06671379","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=nct06671379. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":null,"label":"SHR-A2009 monotherapy","type":"EXPERIMENTAL"},{"description":null,"label":"platinum-based dual-agent chemotherapy","type":"ACTIVE_COMPARATOR"}],"collaborators":[],"completion_date":{"date":"2027-06","type":"ESTIMATED"},"conditions":["Non-small Cell Lung Cancer"],"enrollment":{"count":498,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"SHR-A2009 monotherapy","otherNames":[],"type":"DRUG"},{"name":"platinum-based dual-agent chemotherapy","otherNames":[],"type":"DRUG"}],"last_update":"2026-03-19","lead_sponsor":"Suzhou Suncadia Biopharmaceuticals Co., Ltd.","official_title":"A Randomized, Open-label, Multicenter, Phase III Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic Non-small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy","overall_status":"ACTIVE_NOT_RECRUITING","phases":["PHASE3"],"primary_completion_date":{"date":"2026-12","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Progression-free survival (PFS) assessed by BICR according to RECIST v1.1","timeFrame":"Up to approximately 32 months"}],"references":[],"start_date":{"date":"2024-11-29","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLC","url":"https://clinicaltrials.gov/study/NCT06671379"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/nct06671379"}